AbCellera Biologics reported revenue of $4.05M and net income of -$56.16M for the quarter ended Jun 2026, down 76.3% year over year. This income statement covers 26 quarters of results from Mar 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 281.15M | 283.26M | 284.52M | 285.05M | 285.76M | 288.43M | 286.85M | 286.85M | 286.85M | 293.62M | 290.82M | 290.82M | 290.82M | 298.36M | 295.76M | 295.76M | 299.01M | 300.60M | 303.95M | 306.47M | ||||||
| Revenue & cost | ||||||||||||||||||||||||||
| Revenue | 5.51M | 139.33M | 316.58M | 45.92M | 101.38M | 21.55M | 12.19M | 10.06M | 6.60M | 9.18M | 9.95M | 7.32M | 6.51M | 5.05M | 4.24M | 17.08M | 8.96M | 44.85M | 8.31M | 4.05M | ||||||
| Gross Profit | 5.51M | 117.44M | 271.94M | 40.71M | 86.35M | 20.01M | 12.19M | 10.06M | 6.60M | 9.18M | ||||||||||||||||
| Operating items | ||||||||||||||||||||||||||
| Depreciation & Amortization - TotalDep. & Amort. (Tot) | 1.40M | 2.30M | 2.50M | 2.79M | 2.90M | 3.00M | 3.10M | 3.90M | 3.20M | 3.40M | 3.80M | 2.10M | 4.41M | 4.60M | 4.30M | 5.14M | 5.92M | 6.10M | ||||||||
| Research & DevelopmentR&D | 17.45M | 17.21M | 26.37M | 26.68M | 26.58M | 28.25M | 52.65M | 36.47M | 37.92M | 48.62M | 39.29M | 40.93M | 40.97M | 46.08M | 42.50M | 39.21M | 55.03M | 50.09M | 46.66M | 45.99M | ||||||
| Selling, General & AdministrativeSG&A | 11.27M | 12.89M | 14.27M | 14.41M | 13.79M | 13.02M | 15.13M | 15.52M | 14.37M | 30.15M | 17.35M | 20.19M | 19.15M | 28.80M | 19.07M | 21.99M | 22.05M | 25.98M | 12.33M | 13.85M | ||||||
| Other Operating ExpensesOther Opex | 4.88M | 27.68M | 49.60M | 10.92M | 20.77M | 15.28M | 6.38M | 6.45M | 6.10M | -7.44M | 5.01M | 36.26M | 36.25M | 0.83M | 0.92M | 0.87M | 3.85M | -7.77M | 0.92M | 0.89M | ||||||
| Operating ExpensesOpex | 33.60M | 57.78M | 91.63M | 54.31M | 63.65M | 59.32M | 77.07M | 61.45M | 61.49M | 75.23M | 64.85M | 100.78M | 100.17M | 77.81M | 66.89M | 66.67M | 85.23M | 73.44M | 65.83M | 66.83M | ||||||
| Operating IncomeOp. Inc | -28.10M | 81.55M | 224.95M | -8.40M | 37.73M | -37.78M | -64.87M | -51.39M | -54.89M | -66.05M | -54.89M | -93.45M | -93.66M | -72.75M | -62.66M | -49.59M | -76.28M | -28.58M | -57.52M | -62.78M | ||||||
| EBIT | -28.10M | 81.55M | 224.95M | -8.40M | 37.73M | -37.78M | -64.87M | -51.39M | -54.89M | -66.05M | -54.89M | -93.45M | -93.66M | -72.75M | -62.66M | -49.59M | -76.28M | -28.58M | -57.52M | -62.78M | ||||||
| Non-operating items | ||||||||||||||||||||||||||
| Interest & Investment IncomeInt & Inv Inc | 0.67M | 1.41M | 5.56M | 8.47M | 9.76M | 10.78M | 10.74M | 10.97M | 10.40M | 9.80M | 9.60M | 8.67M | 5.52M | 9.55M | 6.76M | 5.92M | 3.64M | -0.04M | ||||||||
| Other Non Operating IncomeOther Non Op Inc. | 4.38M | 5.31M | 5.19M | 1.53M | 2.15M | 1.68M | 3.59M | 4.58M | 2.83M | 3.38M | 3.27M | 32.16M | 17.94M | 13.71M | 4.15M | 3.69M | 2.73M | 3.32M | 4.34M | 3.85M | ||||||
| Non Operating IncomeNon Op. Inc. | 3.12M | 3.16M | 5.86M | 1.51M | 8.85M | 6.37M | 16.73M | 13.38M | 15.61M | 17.45M | 12.15M | 45.27M | 31.03M | 25.93M | 9.68M | 13.24M | 7.51M | 9.08M | 7.98M | 3.81M | ||||||
| Net income details | ||||||||||||||||||||||||||
| EBT | -24.97M | 84.71M | 230.81M | -6.89M | 46.59M | -31.41M | -48.15M | -38.00M | -39.28M | -48.60M | -42.75M | -48.19M | -62.63M | -46.83M | -52.98M | -36.34M | -68.77M | -19.50M | -49.54M | -58.97M | ||||||
| Tax ProvisionsTaxes | -3.59M | 24.76M | 62.24M | -0.10M | 19.96M | -1.52M | -8.04M | -7.48M | -10.67M | -1.45M | -2.14M | -11.26M | -11.53M | -12.62M | -7.36M | -1.62M | -11.65M | -10.55M | -6.37M | -3.54M | ||||||
| Profit After TaxPAT | -22.89M | 59.58M | 168.57M | -6.79M | 26.62M | -29.89M | -40.11M | -30.53M | -28.61M | -47.41M | -40.61M | -36.93M | -51.11M | -36.87M | -45.62M | -34.73M | -57.16M | -8.95M | -43.16M | -56.16M | ||||||
| Income from Continuing OperationsIncome (Continuing) | -21.38M | 59.95M | 168.57M | -6.79M | 26.62M | -29.89M | -40.11M | -30.53M | -28.61M | -47.15M | -40.61M | -36.93M | -51.11M | -34.21M | -45.62M | -34.73M | -57.12M | -8.95M | -43.16M | -55.43M | ||||||
| Consolidated Net IncomeConsol Net Inc. | -21.38M | 59.95M | 168.57M | -6.79M | 26.62M | -29.89M | -40.11M | -30.53M | -28.61M | -47.15M | -40.61M | -36.93M | -51.11M | -34.21M | -45.62M | -34.73M | -57.12M | -8.95M | -43.16M | -55.43M | ||||||
| Income towards Parent CompanyParent Net Inc | -21.38M | 59.95M | 168.57M | -6.79M | 26.62M | -29.89M | -40.11M | -30.53M | -28.61M | -47.15M | -40.61M | -36.93M | -51.11M | -34.21M | -45.62M | -34.73M | -57.12M | -8.95M | -43.16M | -55.43M | ||||||
| Net Income towards Common StockholdersNet Income | -21.38M | 59.95M | 168.57M | -6.79M | 26.62M | -29.89M | -40.11M | -30.53M | -28.61M | -47.15M | -40.61M | -36.93M | -51.11M | -34.21M | -45.62M | -34.73M | -57.12M | -8.95M | -43.16M | -55.43M | ||||||
| Additional items | ||||||||||||||||||||||||||
| EPS (Basic) | -0.08 | 0.22 | 0.59 | -0.02 | 0.09 | -0.10 | -0.14 | -0.11 | -0.10 | -0.16 | -0.14 | -0.13 | -0.17 | -0.12 | -0.15 | -0.12 | -0.19 | -0.03 | -0.14 | -0.18 | ||||||
| EPS (Diluted) | -0.08 | 0.19 | 0.54 | -0.02 | 0.08 | -0.09 | -0.14 | -0.11 | -0.10 | -0.16 | -0.14 | -0.13 | -0.17 | -0.12 | -0.15 | -0.12 | -0.19 | -0.03 | -0.14 | -0.18 | ||||||
| Shares Outstanding | 278.93M | 275.76M | 283.90M | 284.69M | 285.32M | 285.06M | 287.77M | 288.91M | 289.50M | 289.17M | 292.72M | 294.22M | 294.85M | 294.33M | 297.69M | 298.51M | 298.88M | 298.71M | 303.07M | 305.56M | ||||||
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 278.93M | 318.29M | 311.48M | 284.69M | 315.82M | 314.83M | 287.77M | 288.91M | 289.50M | 289.17M | 292.72M | 294.22M | 294.85M | 294.33M | 297.69M | 298.51M | 298.88M | 298.71M | 303.07M | 305.56M | ||||||
| EBITDA | -28.10M | 81.55M | 226.35M | -6.10M | 40.23M | -34.99M | -61.97M | -48.39M | -51.79M | -62.15M | -51.69M | -90.05M | -89.86M | -70.66M | -58.25M | -44.98M | -71.98M | -23.44M | -51.60M | -56.68M | ||||||
| Tax Rate | 14.38 | 29.23 | 26.96 | 1.47 | 42.85 | 4.84 | 16.69 | 19.67 | 27.16 | 2.99 | 5.00 | 23.36 | 18.40 | 26.95 | 13.90 | 4.45 | 16.94 | 54.13 | 12.86 | 6.00 |